{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:08:56Z","timestamp":1790244536188,"version":"4.1.0"},"reference-count":53,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psychotropic drugs (PD) are often used close to a cancer diagnosis and may be considered as a way of coping. We aimed to determine the incidence of anxiolytics, hypnotics, antidepressants, and antipsychotics initiation around a diagnosis of chronic myelogenous leukemia (CML). Population\u2010based cohort: Data were extracted from <jats:italic>Systeme National des donn\u00e9es de Sant\u00e9<\/jats:italic> (SNDS, the French health insurance database) at the regional level (Midi\u2010Pyrenees area, 2.9 million inhabitants). All newly diagnosed patients treated by a CML tyrosine kinase inhibitor (TKI) between 10\/01\/2011 and 04\/01\/2014 were included. Pre\u2010CML (9\u00a0months before to 3\u00a0months before first TKI prescription\u2014F\u2010TKI) and CML (3\u00a0months before to 9\u00a0months after F\u2010TKI) phases were defined. The main evaluation criterion was the initiation of PD during CML phase. Determinants associated with this incident PD use were studied through a logistic regression model. We compared pre\u2010CML and CML healthcare consumption. The cohort included 103 patients (mean age of 60.8\u00a0years). PD initiation rate was 35.9%, anxiolytics being the most initiated PD (59.5%). Advanced age was associated with PD\u00a0initiation (adjusted OR\u00a0=\u00a01.029, 95% CI\u00a0=\u00a01.001\u20131.056). The number of consultations during the pre\u2010CML phase and female gender tended to be associated with increased risk of PD initiation in univariate analysis. For PD initiators, healthcare consumption was greater in CML but not in pre\u2010CML phase. PD initiation is a frequent finding around a CML diagnosis. Its risk increases with age. It could be a way to identify a subgroup with higher healthcare consumption.<\/jats:p>","DOI":"10.1111\/fcp.12544","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T14:47:22Z","timestamp":1581086842000},"page":"612-622","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population\u2010based study in France"],"prefix":"10.1111","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5338-2071","authenticated-orcid":false,"given":"Martin","family":"Gauthier","sequence":"first","affiliation":[{"name":"D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Conte","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France"},{"name":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Palmaro","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France"},{"name":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"INSERM CIC 1436 Toulouse Centre d\u2019Investigation Clinique de Toulouse Centre Hospitalier Universitaire de Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Patras De Campaigno","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France"},{"name":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"De Barros","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France"},{"name":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Huguet","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Laurent","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France"},{"name":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-5873","authenticated-orcid":false,"given":"Maryse","family":"Lapeyre\u2010Mestre","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France"},{"name":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"INSERM CIC 1436 Toulouse Centre d\u2019Investigation Clinique de Toulouse Centre Hospitalier Universitaire de Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Despas","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France"},{"name":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"},{"name":"INSERM CIC 1436 Toulouse Centre d\u2019Investigation Clinique de Toulouse Centre Hospitalier Universitaire de Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.364"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.0914"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3056"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201500007"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3753"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0483"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020777"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030513"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.7146"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2331-1"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0157"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26679"},{"key":"e_1_2_10_15_1","unstructured":"Inc MG PREDICTION OF THE NUMBER OF CML\u2013 PATIENTS IN GERMANY: UP TO\u2026 by Michael Lauseker.http:\/\/learningcenter.ehaweb.org\/eha\/2015\/20th\/100748\/michael.lauseker.prediction.of.the.number.of.cml.patients.in.germany.up.to.20.html?f=l4269p16m3. Accessed 8 Dec 2018"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347575"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.104"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2372-z"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4123"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2014.11.009"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12214"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4193"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2014.0081"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds252"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551614"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.231"},{"key":"e_1_2_10_28_1","unstructured":"WHOCC \u2010 ATC\/DDD Index.http:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 25 Feb 2015."},{"key":"e_1_2_10_29_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 \u2010 Quelle place pour les benzodiaz\u00e9pines dans l\u2019insomnie ?https:\/\/www.has-sante.fr\/jcms\/c_2015058\/fr\/quelle-place-pour-les-benzodiazepines-dans-l-insomnie. Accessed 29 Oct 2019."},{"key":"e_1_2_10_30_1","unstructured":"Traitement par antid\u00e9presseurs \u2010 ANSM : Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9.https:\/\/ansm.sante.fr\/Dossiers\/Traitements-par-antidepresseurs\/Traitement-par-antidepresseurs\/(offset)\/0. Accessed 29 Oct 2019."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2018.07.007"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000471"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-016-0569-9"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3331-y"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2668-y"},{"key":"e_1_2_10_36_1","first-page":"179","article-title":"Incidence d\u2019un premier cancer avant diagnostic de leuc\u00e9mie my\u00e9lo\u00efde chronique et influence sur le devenir des patients : r\u00e9sultats d\u2019une cohorte monocentrique","volume":"20","author":"Corby A.","year":"2014","journal-title":"H\u00e9matologie"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12436"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12358"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12363"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12298"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3160.3160"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2318-y"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3549-5"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110307"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.51"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3413-7"},{"key":"e_1_2_10_47_1","unstructured":"Insee Midi\u2010Pyr\u00e9n\u00e9es \u2010 L\u2019essentiel sur Midi\u2010Pyr\u00e9n\u00e9es.http:\/\/www.insee.fr\/fr\/regions\/midi-pyrenees\/default.asp?page=faitsetchiffres\/presentation\/essentiel_mp.htm. Accessed 16 Jun 2015"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282632"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2314-2"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.745525"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009418"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006189"},{"key":"e_1_2_10_53_1","unstructured":"JulieP. AllonierC. PhilippeB.et al. (2014)Faisabilit\u00e9 et int\u00e9r\u00eat de l\u2019appariement de donn\u00e9es individuelles en m\u00e9decine g\u00e9n\u00e9rale et de donn\u00e9es de remboursement appliqu\u00e9 au diab\u00e8te et \u00e0 l\u2019hypertension art\u00e9rielle.26355\u2013363."},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1991.tb05513.x"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ffcp.12544","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.12544","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/fcp.12544","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.12544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T19:13:31Z","timestamp":1693941211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.12544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1111\/fcp.12544"],"URL":"https:\/\/doi.org\/10.1111\/fcp.12544","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"2019-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}